IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Lonza Advances Capacity Build in China

9:00 AM MDT | September 12, 2007 | Chemical Week Editorial Staff

Lonza says it will start up a new cGMP pharma manufacturing plant this month at Nansha, China for small-scale campaigns between 10 kilograms and several hundred kilograms. The project is part of Lonza’s previously disclosed plans to create a major pharma manufacturing base at Nansha at a cost of about $200 million (CW, Aug. 1/8, p. 14). The plant closes the gap between Nansha’s kilo lab and the site’s commercial production assets, to allow complete life-cycle support for pharmaceutical products made in China, Lonza says. The small-scale facility...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa